Clinical Trials Browser

OTHER × CP protocol × Clear all

NCT05294900 2026-05-26

NEOS

Phase 2 Completed

79 enrolled 6 charts

Squamous Cell Carcinoma of Head and Neck

NCT06102252 2026-05-22

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Phase NA Completed

Endometrial Neoplasms

NCT04016142 2026-03-18

ACCRAPAN

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT07102940 2026-02-20

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

NCT07401654 2026-02-10

The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression

Phase 2 Not yet recruiting

Ovarian Neoplasms

NCT06353906 2025-12-08

PRIAM

Phase 2 Recruiting

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT05201547 2025-12-04

DOMENICA

Phase 3 Active not recruiting

Neoplasm Metastasis, Endometrial Neoplasms

NCT07107217 2025-08-17

Camella

Phase 2 Not yet recruiting

Breast Neoplasms

NCT04460352 2025-03-06

NEEDS

Phase 3 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Phase 2 Not yet recruiting

Thyroid Neoplasms

NCT01404156 2024-08-28

POWERRANGER

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT04807166 2024-07-03

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

Phase 2 Active not recruiting

Carcinoma, Ovarian Epithelial, Carcinoma, Endocrine System Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms

NCT05992610 2023-08-15

iCHRTL

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Phase 1/2 Completed

Classical hematology

Anemia, Neutropenia, Thrombocytopenia

NCT01367002 2023-05-17

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Phase 2 Completed

61 enrolled 13 charts

Endometrial Neoplasms

NCT05371301 2022-05-12

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Phase 3 Unknown

Ovarian Neoplasms

NCT02878122 2021-08-17

FaCliBioCCo

Ovarian Neoplasms

NCT04982549 2021-08-06

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

Phase 2 Unknown

Unresectable Stage III NSCLC

NCT04137653 2021-07-20

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Phase 3 Recruiting

Breast Neoplasms

NCT04337632 2021-04-08

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Phase 3 Unknown

Ovarian Neoplasms

NCT01314833 2020-05-19

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Phase 3 Completed

Primary Breast Cancer

NCT00226915 2020-02-17

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

Phase 3 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Phase EARLY_PHASE1 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03562533 2019-02-28

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Ovarian Neoplasms

NCT00689156 2018-04-05

READ

Phase 3 Completed

Breast Neoplasms

NCT00584857 2017-01-27

A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer

Phase 2 Completed

30 enrolled 8 charts

Uterine Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

Breast Neoplasms

NCT02207361 2015-12-22

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Phase 4 Unknown

Breast Neoplasms

NCT00538603 2015-12-17

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Phase NA Completed

Carcinoma, Ovarian Epithelial

NCT00919880 2014-08-15

Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00052468 2014-06-25

AGO-OVAR9

Phase 3 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00298415 2013-10-25

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Phase 3 Completed

NSCLC

NCT01872403 2013-06-07

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01196234 2013-01-29

PRIDE

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00340184 2010-10-19

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Phase 2 Completed

Uterine Cervical Neoplasms

NCT01203267 2010-09-16

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

Phase 2 Completed

Pathologic Complete Response, Breast Neoplasms

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00894569 2009-05-14

PACET-CUP

Phase 2 Unknown

Carcinoma, Neoplasms, Unknown Primary

NCT00259675 2007-11-15

Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00144053 2006-01-06

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Phase 3 Completed

Lung Neoplasms